Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Paul

Showing results (821-830 of 1,117) with videos related to

Pageof 112
Sort By:
Future Cardiology|June 20, 2020
Referral decisions based on a prehospital HEART score in suspected non-ST-elevation acute coronary syndrome: design of the FamouS Triage 3 studyDominique N van Dongen, Rudolf T Tolsma, Marion J Fokkert, et al.
European Heart Journal|June 12, 2004
Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplastyGiuseppe De Luca, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
Circulation|May 26, 2004
Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early dischargeGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Thrombosis and Haemostasis|June 4, 2004
Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stentingGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Circulation|February 26, 2004
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failureGiuseppe De Luca, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
Cardiovascular Drugs and Therapy|July 12, 2011
The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarctionRenicus S Hermanides, Gert van Houwelingen, Jan Paul Ottervanger, et al.
Thrombosis and Haemostasis|February 24, 2006
Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary interventionMark B Nienhuis, Jan Paul Ottervanger, Kor Miedema, et al.
Journal of the American College of Cardiology|April 6, 2005
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarctionJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
American Heart Journal|October 8, 2005
Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Arnoud W J van 't Hof, et al.
Drug Delivery|November 28, 2017
Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxelAnne Steins, Eva A Ebbing, Marcel C M Pistorius, et al.
Pageof 112

Showing results (821-830 of 1,117) with videos related to

Sort By:
Pageof 112
Future Cardiology|June 20, 2020
Referral decisions based on a prehospital HEART score in suspected non-ST-elevation acute coronary syndrome: design of the FamouS Triage 3 studyDominique N van Dongen, Rudolf T Tolsma, Marion J Fokkert, et al.
European Heart Journal|June 12, 2004
Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplastyGiuseppe De Luca, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
Circulation|May 26, 2004
Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early dischargeGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Thrombosis and Haemostasis|June 4, 2004
Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stentingGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Circulation|February 26, 2004
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failureGiuseppe De Luca, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
Cardiovascular Drugs and Therapy|July 12, 2011
The impact of age on effects of pre-hospital initiation of high bolus dose of tirofiban before primary angioplasty for ST-elevation myocardial infarctionRenicus S Hermanides, Gert van Houwelingen, Jan Paul Ottervanger, et al.
Thrombosis and Haemostasis|February 24, 2006
Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary interventionMark B Nienhuis, Jan Paul Ottervanger, Kor Miedema, et al.
Journal of the American College of Cardiology|April 6, 2005
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarctionJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
American Heart Journal|October 8, 2005
Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Arnoud W J van 't Hof, et al.
Drug Delivery|November 28, 2017
Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxelAnne Steins, Eva A Ebbing, Marcel C M Pistorius, et al.
Pageof 112